Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER.
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER vs PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 2/0 is a solution used in continuous renal replacement therapy (CRRT) to correct electrolyte imbalances and remove waste products. It provides bicarbonate as a buffer via metabolism of lactate or acetate, and contains electrolytes to maintain homeostasis.
Prismasol B22GK 4/0 is a sterile, bicarbonate-based hemofiltration solution used in continuous renal replacement therapy (CRRT). It replaces electrolytes and buffers in the blood, correcting metabolic acidosis and removing waste products via convection and diffusion. The solution contains bicarbonate as a buffer to maintain acid-base balance.
Continuous renal replacement therapy (CRRT): prescription as per institutional protocol, typically 2000-2500 mL/h effluent rate (dialysate + replacement fluid) for adults. Peritoneal dialysis: 2-3 L exchanges, 4-5 times daily or cycler. Intravenous infusion only via CRRT or as dialysate/replacement fluid.
Continuous renal replacement therapy (CRRT): 1.5-2.0 L/h effluent rate, typically administered as continuous venovenous hemofiltration (CVVH) or hemodiafiltration (CVVHDF). Route: intravenous via CRRT circuit. Frequency: continuous infusion.
None Documented
None Documented
Not applicable; PRISMASOL B22GK 2/0 is a dialysate solution for CRRT. Components (glucose, electrolytes, lactate/bicarbonate) are continuously removed and replaced. For buffer conversion: lactate half-life ~5 minutes (hepatic metabolism to bicarbonate).
Not applicable as a drug; the half-life of infused bicarbonate/lactate in patients is approximately 5–10 minutes for lactate conversion and bicarbonate distribution, but this is not relevant to the solution itself.
Renal (100%); eliminated unchanged by ultrafiltration and diffusion during continuous renal replacement therapy (CRRT). Biliary/fecal: negligible.
Prismasol B22GK 4/0 is a dialysis solution containing electrolytes and buffer (bicarbonate/lactate). It is not systemically absorbed; during continuous renal replacement therapy (CRRT), solutes and fluid are removed via hemofiltration/dialysis. The solution components are eliminated by the dialysis membrane and not subject to systemic excretion.
Category C
Category C
Dialysis Solution
Dialysis Solution